Insight into Sweet's syndrome and associated-malignancy: A review of the current literature

International Journal of Oncology

Volumn 42, Issue 5, 2013, Pages 1516-1522

  Raza, Shahzad ^a   Kirkland, Robert S ^b   Patel, Anand A ^b   Shortridge, James R ^a   Freter, Carl ^a  

^a UNIVERSITY OF MISSOURI   (United States)

^b University of Missouri   (United States)

Author keywords

All trans retinoic acid; Anticancer drugs; Bortezomib; Granulocyte colony stimulating factor; Hypomethylating agents; Lenalidomide; Malignancies; Sweet's syndrome

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; AZACITIDINE; BORTEZOMIB; CLOFAZIMINE; CYCLOSPORIN; DAPSONE; GRANULOCYTE COLONY STIMULATING FACTOR; IMATINIB; INDOMETACIN; LENALIDOMIDE; METHYLPREDNISOLONE SODIUM SUCCINATE; PREDNISONE; RETINOIC ACID;

ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG INDUCED SWEET SYNDROME; DRUG MEGADOSE; DRUG WITHDRAWAL; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; IDIOPATHIC SWEET SYNDROME; MALIGNANCY ASSOCIATED SWEET SYNDROME; MALIGNANT NEOPLASTIC DISEASE; NEUTROPHIL CHEMOTAXIS; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; REVIEW; TREATMENT RESPONSE;

DIAGNOSIS, DIFFERENTIAL; FEVER; HEMATOLOGIC NEOPLASMS; HUMANS; LEUKOCYTOSIS; NEUTROPHILS; RESPIRATORY TRACT INFECTIONS; SWEET SYNDROME;

EID: 84875971387     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.1874     Document Type: Review

References (58)

1. Sweet RD: An acute febrile neutrophilic dermatosis. Br J Dermatol 76: 349-356, 1964.
2. Cohen PR: Sweet's syndrome: a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis 2: 34, 2007.
3. Su WPD and Liu H-NH: Diagnostic criteria for Sweet's syndrome. Cutis 37: 167-174, 1986. (Pubitemid 16083666)
4. von den Driesch P: Sweet's syndrome (acute febrile neutrophilic derma-tosis). J Am Acad Dermatol 31: 535-556, 1994.
5. Cohen PR and Kurzrock R: Sweet's syndrome and cancer. Clin Dermatol 11: 149-157, 1993. (Pubitemid 23191681)
6. Paydas S: Sweet's syndrome: a revisit for hematologists and oncologists. Crit Rev Oncol Hematol: Oct 6, 2012 (Epub ahead of print). doi: 10.1016/j.critrevonc.2012.09.005.
7. Cohen PR, Talpaz M and Kurzrock R: Malignancy-associated Sweet's syndrome: review of the world literature. J Clin Oncol 6: 1887-1897, 1988. (Pubitemid 19089073)
8. Haverstock C, Libecco JF, Sadeghi P, et al: Tender erythematous plaques in a woman with acute myelogenous leukemia. Arch Dermatol 142: 235-240, 2006. (Pubitemid 43276539)
9. Disel U, Paydas S, Yavuz S, et al: Bilateral ear Sweet's syndrome in a case with relapse acute myeloblastic leukemia. Leuk Res 30: 364, 2006. (Pubitemid 43053237)
10. Cohen PR: Cutaneous paraneoplastic syndromes. Am Fam Physician 50: 1273-1282, 1994. (Pubitemid 24337536)
11. Kurzrock R and Cohen PR: Mucocutaneous paraneoplastic mani-festations of hematologic malignancies. Am J Med 99: 207-216, 1995.
12. Kurzrock R and Cohen PR: Cutaneous paraneoplastic syndromes in solid tumors. Am J Med 99: 662-671, 1995. (Pubitemid 26006448)
13. Cohen PR: Cutaneous manifestations of internal malignancy. Section V, Dermatology. In: Current Practice of Medicine. Callen JP and Bone RC (eds). Current Medicine, Philadelphia, PA, Inc, Vol. 2. Issue V. 19.1-19.3, 1996.
14. Cohen PR and Kurzrock R: Paraneoplastic syndromes of the skin. In: Current Diagnosis 9. Conn RB, Borer WZ and Snyder JW (eds). W.B. Saunders Co., Philadelphia, PA, pp1199-1206, 1997.
15. Morgan KW, Callen JP and Kentucky L: Sweet's syndrome in acute myelogenous leukemia presenting as periorbital cellulitis with an infiltrate of leukemic cells. J Am Acad Dermatol 45: 590-595, 2001. (Pubitemid 32917256)
16. Caughman W, Stern R and Haynes H: Neutrophilic dermatosis of myeloproliferative disorders: atypical forms of pyoderma gangrenosum and Sweet's syndrome associated with myeloproliferative disorders. J Am Acad Dermatol 9: 751-758, 1983. (Pubitemid 14230575)
17. Bamelis M, Boyden B, Sente F, et al: Sweet's syndrome and acute myelogenous leukemia in a patient who presented with a sudden massive swelling of the tongue. Dermatology 190: 335-337, 1995.
18. García-Río I, Pérez-Gala S, Aragüés M, et al: Sweet's syndrome on the area of postmastectomy lymphoedema. J Eur Acad Dermatol Venereol 20: 401-405, 2006.
19. Matta M and Kurban AK: Sweet's syndrome: systemic association. Cutis 12: 561-565, 1973.
20. Elsner P, Hartmann AA and Lechner W: Sweet's syndrome associated with Yersinia enterocolitica infection. Dermatologica 173: 85-89, 1986. (Pubitemid 16035783)
21. Arun B, Berberian B, Azumi N, et al: Sweet's syndrome during treatment with all-trans retinoic acid in a patient with acute promyelocytic leukemia. Leuk Lymphoma 31: 613-615, 1998. (Pubitemid 29050604)
22. Paydas S, Sahin B and Zorludemir S: Sweet's syndrome accompanying leukaemia: seven cases and review of the literature. Leuk Res 24: 83-86, 2000.
23. Arbetter KR, Hubbard KW, Markovic SN, et al: Case of granulocytic colony-stimulating factor-induced Sweet's syndrome. Am J Hematol 61: 126-129, 1999. (Pubitemid 29252390)
24. Giasuddin AS, El-Orfi AH, Ziu MM and El-Barnawi NY: Sweet's syndrome: is the pathogenesis mediated by helper T cell type 1 cytokines. J Am Acad Dermatol 39: 940-943, 1998. (Pubitemid 28547725)
25. Tuerlinckx D, Bodart E, Despontin K, et al: Sweet's syndrome with arthritis in a 8-month-old boy. J Rheumatol 26: 440-442, 1999. (Pubitemid 29066752)
26. Kawakami T, Ohashi S, Kawa Y, et al: Elevated serum granulocyte colony-stimulating factor levels in patients with active phase of Sweet syndrome and patients with active Behcet disease: implication in neutrophil apoptosis dysfunction. Arch Dermatol 140: 570-574, 2004. (Pubitemid 38668964)
27. Oiso N, Watanabe K and Kawada A: Granulocyte colony-stimulating factor-induced Sweet syndrome in a healthy donor. Br J Haematol 135: 148, 2006. (Pubitemid 44401610)
28. Shinojima Y, Toma Y and Terui T: Sweet syndrome associated with intrahepatic cholangiocarcinoma producing granulocyte colony-stimulating factor. Br J Haematol 154: 1103-1104, 2006. (Pubitemid 44564545)
29. Requena L, Kutzner H, Plamedo G, et al: Histiocytoid Sweet syndrome: a dermal infiltration of immature neutrophilic granulocytes. Arch Dermatol 141: 834-842, 2005. (Pubitemid 41058064)
30. Walker DC and Cohen PR: Trimethoprim-sulfamethoxazole associated acute febrile neutrophilic dermatosis: case report and review of drug-induced Sweet's syndrome. J Am Acad Dermatol 34: 918-923, 1996. (Pubitemid 26143882)
31. Cohen PR and Kurzrock R: Sweet's syndrome. A neutrophilic dermatosis classically associated with acute onset and fever. Clin Dermatol 18: 265-282, 2000. (Pubitemid 30336506)
32. Bidyasar S, Montoya M, Suleman K, et al: Sweet syndrome associated with granulocyte colony-stimulating factor. J Clin Oncol 26: 4355-4356, 2008.
33. Llamas-Velasco M, García-Martín P, Sánchez- Pérez J, et al: Sweet's syndrome with subcutaneous involvement associated with pegfilgrastim treatment: first reported case. J Cutan Pathol 40: 46-49, 2013.
34. Van Regenmortel N, Van de Voorde K, De Raeve H, et al: Bortezomib-induced Sweet's syndrome. Haematologica 90: ECR43, 2005.
35. Tanguy-Schmidt A, Avenel-Audran M, Croué A, et al: Bortezomib-induced acute neutrophilic dermatosis. Ann Dermatol Venereol 136: 443-446, 2009.
36. Alencar C, Abramowitz M, Parekh S, et al: Atypical presentations of Sweet's syndrome in patients with MDS/AML receiving combinations of hypomethylating agents with histone deacetylase inhibitors. Am J Hematol 84: 688-689, 2009.
37. Trickett HB, Cumpston A and Craig M: Azacitidine-associated Sweet's syndrome. Am J Health Syst Pharm 69: 869-871, 2012.
38. Deininger MW, O'Brien SG, Ford JM, et al: Practical management of patients with chronic myeloid leukemia receiving imatinib. J Clin Oncol 21: 1637-1647, 2003. (Pubitemid 46594119)
39. Liu D, Seiter K, Mathews T, et al: Sweet's syndrome with CML cell infiltration of the skin in a patient with chronic-phase CML while taking Imatinib Mesylate. Leuk Res 28 (Suppl 1): S61-S63, 2004. (Pubitemid 38251500)
40. Ayirookuzhi SJ, Ma L, Ramshesh P, et al: Imatinib-induced Sweet syndrome in a patient with chronic myeloid leukemia. Arch Dermatol 141: 368-370, 2005. (Pubitemid 40365453)
41. Hoverson AR, Davis MD, Weenig RH, et al: Neutrophilic dermatosis (Sweet syndrome) of the hands associated with lenalidomide. Arch Dermatol 142: 1070-1071, 2006. (Pubitemid 44268495)
42. Thieu KP, Rosenbach M, Xu X, et al: Neutrophilic dermatosis complicating lenalidomide therapy. J Am Acad Dermatol 61: 709-710, 2009.
43. Tageja N, Giorgadze T and Zonder J: Dermatological complications following initiation of lenalidomide in a patient with chronic lymphocytic leukaemia. Intern Med J 41: 286-288, 2011.
44. Aue G, Njuguna N, Tian X, et al: Lenalidomide induced upregulation of CD80 on tumor cells correlates with T-cell activation, the rapid onset of a cytokine release syndrome and leukemic cell clearance in chronic lymphocytic leukemia. Haematologica 94: 1266-1273, 2009.
45. Yan ZS, Li DP, Jiang EL, et al: Development of Sweet syndrome in an acute promyelocyte leukemia patient during treatment with all-trans retinoic acid - case report and literature review. Zhonghua Xue Ye Xue Za Zhi 28: 462-465, 2007.
46. Dubois C, Schlageter MH, de Gentile A, et al: Modulation of IL-8, IL-1 beta, and G-CSF secretion by all-trans retinoic acid in acute promyelocytic leukemia. Leukemia 8: 1750-1757, 1994.
47. Bielsa S, Baradad M, Marti RM, et al: Sweet's syndrome with bullous lesions. Actas Dermosifiliogr 96: 315-316, 2005. (Pubitemid 40911033)
48. Shugarman IL, Schmit JM, Sbicca JA, et al: Easily missed extracutaenous manifestation of malignancy associated Sweet's syndrome: systemic inflammatory response syndrome. J Clin Oncol 29: e702-705, 2011.
49. Cohen PR: Neutrophilic dermatoses: a review of current treatment options. Am J Clin Dermatol 10: 301-312, 2009.
50. Cohen PR and Kurzrock R: Sweet's syndrome: a review of current treatment options. Am J Clin Dermatol 3: 117-131, 2002. (Pubitemid 34261192)
51. Spillman DH, Carabajal MG, Errecaborde MS, et al: Acute febrile neutrophilic dermatosis (Sweet's syndrome). In: Book of Abstracts. 18th World Congress of Dermatology. Dermatology: Progress and Perspectives June 12-18, New York City, abs. 147, 1992.
52. Cohen PR, Holder WR, Tucker SB, Kono S and Kurzrock R. Sweet syndrome in patients with solid tumors. Cancer 72: 2723-2731, 1993. (Pubitemid 23320239)
53. Horio T, Imamura S, Danno K, et al: Treatment of acute neutrophilic dermatosis (Sweet's syndrome) with potassium iodide. Dermatologica 160: 341-347, 1980. (Pubitemid 10128846)
54. Burrall B: Sweet's syndrome (acute febrile neutrophilic dermatosis). Dermatol Online J 5: 8, 1999.
55. Bourke JF, Keohane S, Long CC, et al: Sweet's syndrome and malignancy in the U.K. Br J Dermatol 137: 609-613, 1997.
56. Maillard H, Leclech C, Peria P, et al: Colchicine for Sweet's syndrome. A study of 20 cases. Br J Dermatol 140: 565-566, 1999. (Pubitemid 29182913)
57. von den Driesch P, Steffan C, Zobe A, et al: Sweet's syndrome-therapy with cyclosporin. Clin Exp Dermatol 19: 274-277, 1994.
58. Jeanfils S, Joly P, Young P, et al: Indomethacin treatment of eighteen patients with Sweet's syndrome. J Am Acad Dermatol 36: 436-439, 1997. (Pubitemid 27131968)